So MAPS embarked on a decades-lengthy energy to verify that the drug experienced merit to be a drugs, increasing $a hundred and forty million from donors to buy scientific trials. The Firm fashioned what's now Lykos ten years in the past as a public-advantage Company, in anticipation that MDMA-assisted therapy would acquire FDA approval and begin t